CLINICAL_TRIALS
trial_result
· 2022-08-09
Clinical Trial Update: Fecal Microbiota Transplantation for CRE/VRE [Phase 2]
Summary
Phase 2 clinical trial updating the use of fecal microbiota transplantation for carrying CRE/VRE related antimicrobial resistance and colonization.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese University of Hong Kong | Conditions: Antimicrobial Resistance, Colonization | Phase 2 | Status: COMPLETED